<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37346916</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Severe acute polyradiculoneuritis revealing systemic lupus erythematosus: a case report.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2023.45.8.32236</ELocationID><Abstract><AbstractText>Systemic Lupus Erythematosus (SLE) is a common disease with extremely heterogeneous neurological manifestations in its clinical expression. However, few cases have been reported in the last 50 years when the initial manifestation of SLE is Guillain-Barr&#xe9; syndrome (GBS). Our work highlights the importance of evoking SLE as a potential etiology in a patient presenting with acute polyradiculoneuritis. We report the case of a 41-year-old woman who presented with dyspnoea with a purely proxo-distal motor deficit in all four limbs with dermatological lesions such as generalized myxedema and alopecia. The clinical electrical and biological presentation confirms acute polyradiculoneuritis revealing systemic lupus erythematosus. The outcome was marked by clinical improvement, despite the severity of the clinical picture, after treatment with corticosteroid and cyclophosphamide boluses. In conclusion, neurological manifestations in lupus disease are common, whereas the form of acute polyradiculoneuropathy is very rare with a committed vital prognosis. Early diagnosis and management are essential.</AbstractText><CopyrightInformation>Copyright: Assma Boudanga et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boudanga</LastName><ForeName>Assma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Teaching Hospital Mohammed VI, Marrakech, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chraa</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Teaching Hospital Mohammed VI, Marrakech, Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Moroccan Society of Neurophysiology, Marrakech, Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Physiology, Faculty of Medicine and Pharmacy of Marrakech, Marrakech, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhazouani</LastName><ForeName>Oussama Cherkaoui</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Teaching Hospital Mohammed VI, Marrakech, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissani</LastName><ForeName>Najib</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Teaching Hospital Mohammed VI, Marrakech, Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Clinical and Experimental Neuroscience, Faculty of Medicine, Cadi Ayyad University Marrakech, Marrakech, Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8N3DW7272P</RegistryNumber><NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute polyradiculoneuropathy</Keyword><Keyword MajorTopicYN="N">Guillain-Barr&#xe9;</Keyword><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">peripheral neuropathy</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>9</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37346916</ArticleId><ArticleId IdType="pmc">PMC10280964</ArticleId><ArticleId IdType="doi">10.11604/pamj.2023.45.8.32236</ArticleId><ArticleId IdType="pii">PAMJ-45-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rafai MA, Fadel H, Boulaajaj FZ, Gam I, El Moutawakkil B, Karkouri M, et al. Neuropathie P&#xe9;riph&#xe9;rique Dans Le Lupus &#xc9;ryth&#xe9;mateux Syst&#xe9;mique Avec Vasculite &#xc9;pineurale Et Anticorps Antiphospholipides. Rev Neurol (Paris) 2007 Jan;163(1):103&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17304181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha-ou-nou FZ, Dehbi S, Zahlane M, Kissani N, Essaadouni L. Polyradiculoneuropathie Aigu&#xeb; R&#xe9;v&#xe9;lant Le Lupus &#xc9;ryth&#xe9;mateux Syst&#xe9;mique: Une Pr&#xe9;sentation Insolite Avec Des R&#xe9;sultats Mortels. Rev Med Interne. 2014;35:65&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24125571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargour G, MacGaffey K, Locke S, Stein MD. Anterior Radiculopathy and Lupus Erythematosus Cells: Report of Case. Br Med J. 1964 Sep 26;2(5412):799&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1816485</ArticleId><ArticleId IdType="pubmed">14173853</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamichou C, Nikolopoulos D, Genitsaridi I, Bortoluzzi A, Fanouriakis A, Papastefanakis E, et al. In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Ann Rheum Dis. 2020 Feb;79(2):232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">31704720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait Benhaddou E, Birouk N, El Alaoui-Faris M, Mzalek-Tazi, Aidi S, Belaidi H, et al. Polyradiculon&#xe9;vrite aigu&#xeb; de type Guillain Barr&#xe9; r&#xe9;v&#xe9;lant un lupus &#xe9;ryth&#xe9;mateux aigu diss&#xe9;min&#xe9;: &#xe9;tude de deux cas et revue de la litt&#xe9;rature. Rev Neurol (Paris) 2003 Mar;159(3):300&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12703046</ArticleId></ArticleIdList></Reference><Reference><Citation>Omdal R, Loseth S, Torbergsen T, Koldingsnes W, Husby G, Mellgren SI. Peripheral neuropathy in systemic lupus erythematosus-a longitudinal study. Acta Neurol Scand. 2001 Jun;103(6):386&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11421851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingisser R, Speich R, Fontana A, Gmur J, Vogel B, Landis T. Lupus Erythematosus and Miller-Fisher Syndrome. Arch Neurol. 1994 Aug;51(8):828&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">8042933</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadri Q, Althaf MM. Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus-case report and review of literature. Ann Saudi Med. 2015 May-Jun;35(3):263&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6074455</ArticleId><ArticleId IdType="pubmed">26409804</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago Casas Y, Peredo RA, Vila LM. Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain-Barre syndrome-like acute axonal neuropathies: report of two cases. Lupus. 2013 Mar;22(3):324&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23439473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lef&#xe8;vre G, Z&#xe9;phir H, Warembourg F, Michelin E, Pruvo JP, Hachulla E, et al. Neurolupus (1repartie) Description et d&#xe9;marche diagnostique et th&#xe9;rapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus &#xe9;ryth&#xe9;mateux syst&#xe9;mique. Rev Med Interne. 2012 Sep;33(9):491&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579860</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>